Related Experiment Video
Updated: Aug 18, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
Familial hypercholesterolemia in children
J Rodenburg1, M N Vissers, A Wiegman
1Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands.
Insights
Children with familial hypercholesterolemia experience accelerated atherosclerosis. Early statin therapy is safe and effective in reducing low-density lipoprotein cholesterol and improving arterial health in these children.
Area of Science:
- Pediatric Cardiology
- Genetics
- Cardiovascular Disease
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol levels from birth.
- Children with FH face an increased risk of premature cardiovascular disease due to accelerated atherosclerosis.
- Early detection and intervention are crucial for managing FH in pediatric populations.
Purpose of the Study:
- To review recent advancements in diagnosing and managing pediatric familial hypercholesterolemia.
- To highlight the impact of early lipid-lowering interventions on cardiovascular health in children with FH.
Main Methods:
- Cross-sectional cohort study analyzing intima-media thickness progression in children with FH.
- Evaluation of low-density lipoprotein cholesterol as a predictor of atherosclerosis.
- Assessment of statin therapy and plant sterol products for lipid reduction and surrogate marker improvement.
Main Results:
- Children with FH showed a 5-fold faster increase in carotid arterial wall intima-media thickness compared to unaffected siblings.
- Low-density lipoprotein cholesterol levels were a strong predictor of intima-media thickness.
- Statin therapy led to regression of intima-media thickness and was found to be safe in children, without impairing growth or development.
- Plant sterols reduced low-density lipoprotein cholesterol but did not improve endothelial function.
Conclusions:
- Children with FH significantly benefit from lipid-lowering strategies, particularly statins.
- Statins are safe and effective in reducing low-density lipoprotein cholesterol and improving atherosclerosis markers in pediatric FH.
- Early initiation of statin therapy is recommended as the pivotal treatment for children with familial hypercholesterolemia.
Purpose Of This Review:
This review provides an update on recent advances in the diagnosis and management of children with familial hypercholesterolemia.
Recent Findings:
A large cross-sectional cohort study of paediatric familial hypercholesterolemia demonstrated that affected children had a 5-fold more rapid increase of carotid arterial wall intima-media thickness during childhood years than their affected siblings. This faster progression led to a significant deviation in terms of intima-media thickness from the age of 12 years and onwards. Low-density lipoprotein cholesterol was a strong and independent predictor of carotid artery intima-media thickness in these children, which confirms the pivotal role of low-density lipoprotein cholesterol for the development of atherosclerosis. In this condition lipid lowering by statin therapy is accompanied by carotid intima-media thickness regression in familial-hypercholesterolemic children, which suggests that initiation of low-density lipoprotein cholesterol-reducing medication in childhood already can inhibit or possibly reduce the faster progression of atherosclerosis. Furthermore, these trials demonstrated that statins are safe and do not impair growth or sexual development in these children. Conversely, products containing plant sterols reduced low-density lipoprotein cholesterol levels by 14%, but did not improve endothelial dysfunction as assessed by flow-mediated dilatation.
Summary:
Children with familial hypercholesterolemia clearly benefit from lipid-lowering strategies. Statins are safe agents and have been proven to reduce elevated low-density lipoprotein cholesterol levels significantly. In addition, statins improve surrogate markers for atherosclerosis. Therefore these agents should become the pivotal therapy in children with familial hypercholesterolemia.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Lipid Catabolism

